cURL Error: Failed to connect to 217.15.170.3 port 80 after 1041 ms: Couldn't connect to server Monitoring of REGN situation on June 27, 2025
Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target

Published on June 27, 2025
Regeneron Pharmaceuticals Inc. has been making waves in the biotech industry, with impressive financial and operating results. Despite this, UBS recently lowered their price target on the company, causing a stir among investors. It will be interesting to see how this development affects the stock price in the coming weeks. Analysts recommend seeking professional advice from Stocks Prognosis for a better understanding of the potential movement of REGN shares.
Go to REGN Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for REGN

Regeneron Pharmaceuticals Inc. REGN Leads Biotech Industry with Innovative Drug Developments

January 18, 2026

Regeneron Pharmaceuticals Inc. REGN Receives Positive Opinion from European Medicines Agency

October 31, 2025

Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance

September 5, 2025

Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals

July 5, 2025

REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin

June 5, 2025

REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit

June 5, 2025

Related Data

Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance

September 5, 2025

Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report

January 22, 2025

Regeneron Pharmaceuticals Inc. REGN Receives Positive Opinion from European Medicines Agency

October 31, 2025

Regeneron Pharmaceuticals Inc. REGN Leads Biotech Industry with Innovative Drug Developments

January 18, 2026

Deadline Alert: Regeneron Pharmaceuticals Inc. REGN

January 25, 2025